How can I enroll in this study?
_________________________
What
is sudden sensorineural hearing loss?
Study overview
What
is intratympanic steroid therapy? (Flash video)
What
are the entry criteria?
What
if I have limited or no medical insurance?
___________________________
Eight
centers around the U.S. initially participated in this clinical
study, and this has been expanded to eight more centers in the U.S. and Canada - check our list of centers for a list of participating clinics
__________________________
Johns Hopkins Hospital in Baltimore, Maryland,
recruited the first patient for the SSNHL trial on Dec 22, 2004.
A total of 254 patients will be enrolled in this five year
study.
___________________________
information for SSNHL investigators
___________________________
if you are UNABLE to contact one of our study centers, AND you have SSNHL within 2 weeks of the symptoms, you can also contact us at:
hearingresearch@gmail.com
|
Participating centers in the Sudden Sensorineural Hearing Loss Multicenter Treatment Trial
Canada
California
Florida
Iowa
Maryland
New England
Michigan
Missouri
New York
Ohio
Texas
Baylor College of Medicine, Dept. of Otolaryngology – Head and Neck Surgery, Houston, TX 77030-3411
Clinical Coordinator: Sharon L. Congdon
Tel 713-798-5819
scongdon@bcm.tmc.edu
Jeffrey T. Vrabec, MD, Principal Investigator
UT Southwestern Medical Center, Dept. of Otolaryngology/Head and Neck Surgery, Dallas, TX 75390-9035
Clinical Coordinator: Barbara Staves
Tel 214-648-9793
barbara.staves@utsouthwestern.edu
Clinical Research Coordinator
5323 Harry Hines Blvd.; H1.126
Dallas, TX 75390-9035
ofc 214.648.9793
fax 214.648.6733
pager 972.326.1133
Brandon Isaacson, MD, Principal Investigator
|
